Methods, systems, and computer readable media for image guided ablation

Information

  • Patent Grant
  • 9265572
  • Patent Number
    9,265,572
  • Date Filed
    Friday, July 23, 2010
    14 years ago
  • Date Issued
    Tuesday, February 23, 2016
    9 years ago
Abstract
The subject matter described herein includes methods, systems, and computer readable media for image guided ablation. One system for image guided ablation includes an ultrasound transducer for producing a real-time ultrasound image of a target volume and of surrounding tissue. The system further includes an ablation probe for ablating the target volume. The system further includes a display for displaying an image to guide positioning of the ablation probe during ablation of the target volume. The system further includes at least one tracker for tracking position and orientation of the ablation probe during the ablation of the target volume. The system further includes a rendering and display module for receiving a pre-ablation image of the target volume and for displaying a combined image on the display, where the combined image includes a motion tracked, rendered image of the ablation probe and an equally motion tracked real-time ultrasound image registered with the pre-ablation image.
Description
TECHNICAL FIELD

The subject matter described herein relates to image guided medical treatment systems. More particularly, the subject matter described herein relates to methods, systems, and computer readable media for image guided ablation.


BACKGROUND

Ablation, such as radio frequency ablation (RFA), microwave ablation, and cryo-ablation, is a first-line treatment for non-resectable hepatic and other types of tumors. RFA is a minimally invasive intervention (MII) uses high-frequency electrical current, introduced—under 2D ultrasound guidance—via a percutaneous needle-like probe, to heat the targeted tissues to physiologically destructive levels. RFA probes are characterized by manufacturer-specified ablation zones that are typically spheres or ellipsoids. The interventional radiologist who performs the procedure must place the probe such that the entire tumor as well as a safety boundary of several millimeters thickness are contained within the predicted ablation area. Frequent tumor recurrence on the periphery of the original tumor [1] indicates that probe placement accuracy may be a major cause for the low 5-year survival rates of hepatic carcinoma patients.


It is believed that physicians will more accurately target RFA to hepatic and other tumors using a contextually correct 3D visualization system than with standard 2D ultrasound alone. If proven beneficial, 3D guidance could decrease the high post-RFA tumor recurrence rate [3]. Prior experience in developing and evaluating a guidance system for breast biopsy [5] yield results that support this hypothesis.


Accordingly, there exists a long-felt need for methods, systems, and computer readable media for image guided ablation.


SUMMARY

The subject matter described herein includes methods, systems, and computer readable media for image guided ablation. One system for image guided ablation includes an ultrasound transducer for producing a real-time ultrasound image of a target volume to be ablated and surrounding tissue. The system further includes an ablation probe for ablating the target volume. The system further includes a display for displaying an image to guide position of the ablation probe during ablation of the target volume. The system further includes at least one tracker for tracking position of the ablation probe during the ablation of the target volume. The system further includes a rendering and display module for receiving a pre-ablation image of the target volume and for displaying a combined image on the display, where the combined image includes a motion tracked, rendered image of the ablation probe and the real-time ultrasound image registered with the pre-ablation image of the target volume.


The subject matter described herein for image guided ablation may be implemented using a computer readable medium comprising computer executable instructions that are executed by a computer processor. Exemplary computer readable media suitable for implementing the subject matter described herein includes disk memory devices, programmable logic devices, and application specific integrated circuits. In one implementation, the computer readable medium may include a memory accessible by a processor. The memory may include instructions executable by the processor for implementing any of the methods described herein for image guided ablation. In addition, a computer readable medium that implements the subject matter described herein may be distributed across multiple physical devices and/or computing platforms.





BRIEF DESCRIPTION OF THE DRAWINGS

The subject matter described herein will now be explained with reference to the accompanying drawings of which:



FIG. 1A is an image of an RFA guidance system with a see-through head-mounted display.



FIG. 1B is a view from inside a head mounted display (HMD) with 3D guidance graphics indicating relationship between needle-like RFA probe and ultrasound image plane;



FIG. 2A is a see through head mounted display (ST-HMD) view of an ultrasound transducer with infrared LEDs for motion tracking. The dark rectangle below the transducer is an ultrasound image produced by the ultrasound transducer.



FIG. 2B, from top to bottom, illustrates images of a motion-tracked RFA probe with deployable tines and real-time registered guidance graphics, the ablation region (in this example a sphere) is scaled based on current tine deployment.



FIG. 3 displays modalities under consideration for the image ablation 3D guidance system, both using optoelectronic tracking (overhead). Left: ST-HMD provides virtual image inside of and registered with the patient (cf. FIGS. 1A and 1B). Right: fish tank VR system shows 3D virtual image above patient (cf. FIGS. 5 through 8).



FIG. 4 is a block diagram illustrating an exemplary system for image guided ablation according to an embodiment of the subject matter described herein (this is a fish tank VR system as illustrated in FIG. 3, right).



FIG. 5 is Left: RFA guidance system in use on a woodchuck with liver tumors. The interventional radiologist wears polarized glasses and a large but lightweight head tracker with infrared LEDs. He holds a tracked ultrasound transducer (left hand) and a tracked RFA probe (right hand). The stereoscopic display (a commercial unit consisting of two LCD panels and a half-silvered mirror) is also equipped with an LED tracking panel on the right side. Right: View inside the stereoscopic display shows the transducer, the echography image, and the RFA probe (cf. FIG. 1B). The ablation region (cf. FIG. 2B) is also shown (wireframe sphere). The target volume (tumor) is visible as a partially hollowed out spherical object.



FIG. 6 is a diagram of a rendered image of a target volume and an ultrasound transducer prior to an ablation pass according to an embodiment of the subject matter described herein.



FIG. 7 is a rendered image of a target volume, an ultrasound transducer, an RFA probe, and a predicted treatment volume according to an embodiment of the subject matter described herein.



FIG. 8 is a rendered image of a target volume with the region treated by a prior ablation pass subtracted from the target volume, a predicted treatment volume, and the RFA probe in ultrasound transducers according to an embodiment of the subject matter described herein.



FIG. 9 is a view of a head-tracked virtual environment suitable for use with an image guided ablation guidance system according to an embodiment of the subject matter described herein. In FIG. 9, the tracked medical instruments (ultrasound transducer and RFA probe are not shown. A tracked hand-held pointer used for eye calibration can be seen.



FIG. 10 illustrates an eye calibration setup and sequence, shown for the left eye only.



FIG. 11 is a series of images that illustrate as the user moves about the display, the virtual imagery in the display (in this case a human head for illustrative purposes) is shown from the proper perspective (i.e., from the user's eyes. The three images were photographed with the display's stereo mirror in place (cf. FIGS. 5 left and 9) and show both eyes' views simultaneously (the stereo mirror reflects the right eye view from the top LCD monitor.



FIG. 12 is an image of an ultrasound transducer, an ultrasound image, a target volume, and an anatomical context that may be produced by a rendering and display module according to an embodiment of the subject matter described herein.





DETAILED DESCRIPTION

The subject matter described herein includes methods, systems, and computer readable media for image guided ablation. The following paragraphs describe how an exemplary implementation of the present subject matter was designed, comparing the two designs introduced in FIG. 3: a see through head mounted display and a fish tank virtual reality display.


1. Choosing a Display System


Our research team has developed 3D guidance for MIIs since the mid-1990s; all our systems were based on see-through head-mounted displays (ST-HMDs) [6]. We demonstrated superior targeting accuracy in breast lesions when comparing ST-HMD guidance with the standard 2D method [5]. In addition to stereoscopy and head-motion parallax, the system based on motion-tracked ST-HMDs provided a view of the patient that included a synthetic opening into the patient, showing live echography data and 3D tool guidance graphics in registration with the “real world,” and therefore also with the patient (FIG. 1B) as well as with the motion-tracked instruments (note FIG. 2A, which shows the ultrasound transducer in an early RFA guidance system prototype based on a video see-through HMD).


Stereoscopic visualization with head-motion parallax can also be implemented with fixed displays, i.e. without mounting the display on the user's head. Such “fish tank” displays may use CRT monitors and frame-sequential shutter glasses [2], or (at a larger scale) projection displays and passive polarized glasses, for example. Recently, devices based on LCD panels and a semi-transparent mirror have become available from Planar Systems, Inc. [4]; these use passive linearly polarized glasses.


While we obtained encouraging results in the past with ST-HMD systems, we are disappointed with the bulky and uncomfortable, low-resolution devices resulting from today's state of the art in HMDs. Moreover, since there are no satisfactory video see-through devices on the market, we always constructed our own, with rather modest resources [6]. For these reasons, when designing the RFA 3D guidance system, we considered both an ST-HMD approach and a commercial fish tank system (FIG. 3). With respect to the “augmented reality” (AR) view provided by the ST-HMD, we noted that in Mils—our driving problem—the “interface” between the relevant components of the real world (in our case, the patient, the RFA probe and the ultrasound transducer) and the virtual display (in our case, the echography image, the RFA probe representation inside the patient, and the 3D guidance graphics) is essentially limited to the location where the RFA probe penetrates the skin (FIG. 1A). Furthermore, once the probe pierces the skin, it is moved only lengthwise through this entry point, which is no longer under constant observation by the radiologist. The radiologist then focuses on internal anatomy as he guides the probe into the tumor. From this we conclude that MII (our driving problem) may in fact not derive much benefit from exact registration between real and virtual imagery as provided by an ST-HMD, at least not during the most critical final phase of the probe targeting approach, as the probe tip is introduced into the tumor.


The above considerations led us to favor a fish tank type display even though it does not offer registration between virtual display and internal patient anatomy. Since our display metaphor proposes life-size representations of the ultrasound image and of the ablation probe, projection displays are unsuitable; and CRT-based stereo has disadvantages such as the requirement for active stereo glasses, which can exhibit flicker. The Planar SD1710 display [4] was almost ideally suited: its small 17-inch 1280×1024 display can fully contain our 3D display elements at life size. Furthermore, it does not exhibit flicker and has manageable bulk.



FIG. 4 is a block diagram illustrating an exemplary system for image guided ablation according to an embodiment of the subject matter described herein. Referring to FIG. 4, the system includes an ultrasound transducer 400 for producing a real-time ultrasound image of a target volume to be ablated and surrounding tissue. Ultrasound transducer 400 may be any suitable ultrasound transducer, such as the type commonly used for surgery, diagnosis, and patient monitoring. Such a transducer produces a real time ultrasound image of the area of the patient near the contact point of the ultrasound transducer with the patient. One disadvantage associated with ultrasound images is that they are usually two-dimensional and they lack the detail of other image types, such as CT and MRI images.


In FIG. 4, the system further includes an ablation probe 402 for ablating the target volume. An exemplary ablation probe suitable for use with embodiments of the subject matter described herein includes the LeVeen RFA needle electrode probe available from Boston Scientific. Probe 402 may also include a tine deployment tracker 404 for tracking deployment of the probe tines (for RFA ablation probes). In one implementation, tine deployment tracker 404 may include a light emitting diode attached to the probe to measure movement of the plunger within the probe that indicates the length of the portions of the tines that are deployed. The LED may be mounted on the plunger and its motion relative the probe handle can be observed by a tracking system. In an alternate embodiment, a linear potentiometer may be used to track tine deployment.


The system illustrated in FIG. 4 further includes a headband 406 to be worn by the user of ablation probe 402. Headband 406 may include a cluster of infrared or other suitable LEDs for tracking purposes. The purpose of headband 406 is to track position and orientation of the user's head to be used in rendering a combined image from the viewpoint of the user onto the stereoscopic fish tank display. A tracker 408 tracks position of the ultrasound transducer 400, ablation probe 402, headband 406, and display 410. Any suitable tracking system for tracking such components can be used. In one implementation, tracker 408 includes a sensor that senses infrared signals from LEDs mounted to ultrasound transducer 400, ablation probe 402, headband 406, and display 410 and computes the positions and orientations of these elements from the signals detected from the LEDs. A triangular LED arrangement 501 suitable for tracking display 410 is shown in FIG. 5 (left) and FIG. 9. Commercially available trackers suitable for use with the subject matter described herein include infrared trackers available from PhaseSpace or Northern Digital, Inc.


The subject described herein is not limited to using a fish tank VR display. As stated above, a virtual see through head mounted display may be used without departing from the scope of the subject matter described herein. In an embodiment that uses a virtual see through head mounted display, tracker 408 can track both the display and the user's head using headband 406, since the display is worn on the user's head.


A rendering and display module 412 receives the real-time ultrasound image, pre-ablation image data, tracking data from tracker 408, produces combined, stereoscopic, head tracked imagery and displays the imagery on display 410. The combined imagery may include a motion tracked, rendered image of the RFA probe, the real-time ultrasound image registered with the pre-ablation image of the target volume, shown from a viewpoint of the user. Exemplary images that may be computed and displayed by rendering and display module 412 will be illustrated and described in detail below.


2. Display System Implementation Details


In one exemplary implementation of the present subject matter, a motion tracker is mounted on the display as in handheld augmented reality applications. Thus, both the tracker base and the stereoscopic display can be moved relative to each other at any time without recalibration to adjust for space and/or line-of-sight constraints within the operating environment; this aims to improve visibility of the tracked system components by the tracker and thereby tracking accuracy and/or reliability. The control software, i.e., rendering and display module 412, ensures that the 3D display preserves orientation; e.g., the virtual representations of tracked devices such as the RFA probe in the display are always shown geometrically parallel to the actual devices, in this case the handheld ablation probe 402. The same applies to the ultrasound transducer 400. In other words, as opposed to the registration in both position and orientation provided by the ST-HMD, this technique maintains only orientation alignment; it introduces a translational offset between the location of the instruments in the real world on the one hand, and their virtual counterparts in the 3D display on the other hand. The interface implemented by rendering and display module 412 has three presentation modes that differ in how these user-induced translational movements of the instruments are echoed in the 3D display (orientation changes are always fully shown, as mentioned):

    • A. Centered mode: The ultrasound image is always shown in the center of the 3D display. It is not possible to move the ultrasound transducer such that it leaves the display area.
    • B. Free mode: The user can interactively define the position offset between an area within the patient and the 3D space seen inside the display. Translational motion of the instruments is shown fully within the display, and it is possible to move the ultrasound transducer such that it leaves the display area.
    • C. Delayed mode: This is a combination of the above two modes. The ultrasound image is initially centered as in (A), but the user may move the ultrasound transducer, even outside the display. However after a short lag, the system “catches up” and re-centers the ultrasound image. This allows the user to perceive high-speed translational motion of the ultrasound transducer and image; at low speeds or statically, this is equivalent to (A), at high speeds, to (B).


      For all three modes above, rendering and display module 412 continually calculates the appropriate transformations for the RFA probe, in order to always show the correct pose relationship between it and the ultrasound image.


Given the small size of the display, it is important for the system to accurately track the user's eyes, in order to minimize geometric distortions. A fast and accurate method to calibrate the user's eyes to the head tracker is referenced in the context of which is set forth below [7].


Table 1 summarizes the principal characteristics of the two display techniques we have considered using for the RFA guidance system (ST-HMD and fish tank VR system).









TABLE 1







Characteristics of the two display technologies under consideration










See-through HMD
“Fish tank” VR system





Availability
Custom-designed and
Commercially available



built



Display
Fixed to user's head,
Fixed to room, but


configuration
motion-tracked with
motion-tracked (can be



head
moved)


Head gear
ST-HMD, tracker
Lightweight glasses,




tracker


Resolution
800 × 600 in our recent
1280 × 1024 in current



build; higher resolution
device, available at



yields bulkier device
higher resolutions


Registration
Yes (“true” augmented
Partial only: orientation


between patient and
reality)
alignment but offset in


ultrasound image

position


(and between RFA




probe and its virtual




representation)










3. Using the Head-Tracked Fish Tank Stereoscopic Display


At present there is no controlled study comparing the performance of the head-tracked fish tank display to an ST-HMD device. An interventional radiologist (Charles Burke, MD, UNC Radiology) who has used the head-tracked fish tank display extensively, reports that depth perception is good and that the display correctly portrays three-dimensional relationships during RFA probe targeting. A depth perception study conducted with this display revealed that most subjects (a randomly selected group of 23) were able to determine which of two objects located only a few millimeters apart in depth was closer, based solely on stereoscopic and motion parallax cues provided by the fish tank display.


The present 3D RF ablation guidance system has been tested on specially constructed liver phantoms; the completed system is currently used in a controlled animal study to ablate liver carcinomas in woodchucks (FIG. 5, left). The study randomizes each woodchuck to either the ultrasound-only conventional guidance method or to the present ultrasound-with-3D-guidance technique.


According to one aspect of the subject matter described herein, rendering and display module 412 may display the target volume, such as the tumor, with successively smaller size as ablated regions are eliminated from display with each ablation pass. Such an image is useful for multiple pass techniques that are aim to treat a large tumor with multiple overlapping ablations. In one embodiment, an initial target volume to be ablated may be shown as a three dimensional structure on a display screen. The initial target volume may be rendered from the pre-ablation image data, such as MRI or CT image data. FIG. 6 illustrates an example of an initial target volume that may be displayed by rendering and display module 412. In FIG. 6, three dimensional region 600 represents the initial target volume. Rendering 602 represents ultrasound transducer 400 and its real time orientation. Rendering 604 represents the real time ultrasound image continuously produced by ultrasound transducer 400. Rendering 602 is a virtual representation of ultrasound transducer 400 or, in other words, the ultrasound transducer's avatar.


After a first ablation pass, the volume affected by the first ablation pass may be subtracted from the displayed representation of the initial target volume. The volume affected by the first ablation pass may be determined mathematically based on the position of the ablation probe at the time of the first ablation pass, the geometry of the ablation probe, and the tine deployment and power settings of the ablation probe during the first ablation pass. For example, if the probe is the above-referenced LeVeen needle electrode probe, the affected volume for an ablation pass may be determined based on manufacturers specifications. In one current implementation, a constant ellipsoid based on what the probe data sheet indicates is used as the affected ablation volume may be subtracted from the image of the target volume. In alternate implementations, pre-calibrated volumes (shapes measured in a test ablated human-organ-like phantom) or varying the shape based on time deployment can be used to determine the affected sub volume. However, the probes are usually specified to be used with fully deployed times, and manufacturers do not give partial deployment information. Additional bio-chemo-thermo-geometric calibration and simulation work, possibly taking into account fluid flow through blood vessels, may be utilized to increase the accuracy of the affected ablation volume estimates.



FIG. 7 illustrates initial target volume 600 with the region affected by the first ablation pass shown surrounded by a wireframe region 700 that represents a predicted ablation area. A rendering 702 representing ablation probe 402 and its current orientation is also shown. Rendering 704 represents 3D guidance graphics produced by rendering and display module 412. In the illustrated example, the 3D guidance graphics include a calculated projection of ablation probe 402 onto the plane defined by the current position and orientation of the ultrasound image 604; projection lines connect ablation probe 402's needle to the calculated projection at regular intervals. This is useful in assessing the spatial relationship between ablation probe 402 and the ultrasound image; the probe only appears in the ultrasound image when the two are coplanar, that is, when ablation probe 402's needle coincides with its projection and the projective lines have collapsed to zero length. The predicted ablation area may also be determined based on the current position of the probe, the power settings, tine deployment, and the manufacturer's specification. Once the volume determined by the first ablation pass is determined, that volume can be subtracted and the remaining volume can be displayed to the user in the next ablation pass. FIG. 8 illustrates an example of subtracting the volume affected by the first ablation pass from initial target volume 600 illustrated in FIG. 6. In FIG. 8, concave surface area 800 illustrates the results of subtracting the volume of initial target volume 600 affected by the first ablation pass from the initially displayed target volume. This subtracting can be repeated for successive ablation passes until target volume 600 is eliminated. The display of surfaces 600 and 800 can be formed in real-time using polygon rendering of the isosurface calculated from the affected volume, for example, using the well known marching cubes isosurface extraction technique. As another example of the display of the target volume affected by successive ablation passes, the image on the right-hand side of FIG. 5 is another example of volume carving visualization that may be rendered by rendering and display module 412 after multiple ablation passes. In FIG. 5 (right), region 500 represents the rendering of the target volume from pre-treatment data, such as MRI or CT data. Region 604 represents the real-time ultrasound image produced by ultrasound transducer 400, which is also represented in the display in FIG. 5 by three-dimensional rendering 602. It should be noted that in the illustrated example, pre-treatment image 500 is registered with real-time ultrasound image 604. Further, the combined image is shown from the viewpoint of the user.


Region 504 illustrated in FIG. 5 represents the portion of target volume 500 that is affected by multiple ablation passes. Wireframe mesh 700 represents the treatment volume that will be affected based on the current position of the RFA probe. Such rendering may be particularly suitable for treating large lesions to inform the interventional radiologist of portions of a large tumor that have already been ablated as well as of those that still remain to be treated.


As stated above, rendering and display module 412 may both calculate and display in real-time the amount of tumor and background tissue that would be ablated for the momentary location of the ablation probe, in order to illustrate on the display the impact of probe position. The calculation and display of the amount of tumor and background tissue that would be affected by an ablation can be performed in real-time or may use a lookup table based on the geometry and location of the probe. As stated above, the affected volume can be determined using the data from the probe manufacturer or using experimental data. The volume that would be affected by the ablation can be super imposed about the ablation probe position and displayed to the user. FIG. 7 illustrates an example of displaying the amount of tumor and background tissue that would be ablated for a particular location of the ablation probe. In FIG. 7, relative amounts of healthy and tumor tissue that would be affected by the ablation pass are shown as vertical bars in the lower left hand corner in different shading. Such a display may be useful in probe positioning to maximize the proportion of tumor tissue that is treated with respect to healthy tissue.


According to another aspect of the subject matter described herein, the guidance system will benefit from accurate registration of the user's eyes for precise head tracked stereoscopic visualization. An exemplary method for accurate registration of the user's eyes for precise head tracked stereoscopic visualization will now be described.


The high accuracy is achieved in the same calibrated, stereoscopic head-tracked viewing environment used by the guidance system. While the current implementation requires a head-mounted tracker, future embodiments may use un-encumbering tracking, such as vision-based head pose recovery. It is important to note that the technique described here does not require pupil tracking; it uses only head pose, which can generally be obtained less intrusively, with higher reliability, and from a greater distance away than camera-based pupil tracking. An additional pupil tracker is not required unless the system must know the user's gaze direction, for example in order to record user behavior in training-related applications [14].


2. Calibration System for Exact Eye Locations


The calibration system uses the following main components (FIG. 9):

    • a Planar Systems SD1710 (“Planar”) stereoscopic display with two 17″ LCD monitors and a semi-transparent mirror that reflects the upper monitor's image onto the lower monitor. The user wears linearly polarized glasses that restrict viewing of the lower monitor to the left eye and viewing of the upper monitor's reflection to the right eye. The LCDs' native resolution is 1280×1024.
    • a sub-millimeter precision Northern Digital Optotrak Certus optoelectronic tracking system (“Certus”). Both the Planar and the user's head are tracked by the Certus in all six degrees of freedom with clusters of infrared (IR) LEDs (11 on the head, 4 on the Planar). As mentioned, the advantage of tracking the display as in handheld augmented reality applications [15] is that both the display and the tracker can be moved with respect to each other while the system is running, for example, to improve LED visibility. The Certus also provides a calibration stylus for precise measurements (visible in FIG. 9).


      The user dons the head tracker and performs a simple, fast eye calibration procedure.


      2.1. Projection Origin and Eye Calibration


In fish tank VR systems, the calibration between the head tracker and the eyes is usually obtained from measurements such as the user's inter-pupillary distance (IPD, measured with a pupillometer) [8], the location of the tracker on the user's head, as well as from assumptions about the most suitable location of the projection origin inside the eye. Popular choices for the latter include the eye's 1st nodal point [2], the entrance pupil [9], and the center of the eye [10]. Our method uses the eye center [10] because it is easy to calibrate and yields exact synthetic imagery in the center of the field of view regardless of the user's gaze. However, the 1st nodal point and the entrance pupil are better approximations for the actual optics within the eye. Therefore, by rendering stereo images from the eye centers, i.e. from a few mm too far back, and thus with a slightly exaggerated separation, the EEC system deforms the stereoscopic field [11] ever so slightly. For higher accuracy, a pupil tracker could detect the user's gaze directions, and assuming that the user converges onto the virtual object found along those directions, the rendering and display module could move the projection origins forward to the 1st nodal point, or all the way to the pupil.


Calibration.


The eye calibration technique (FIG. 10) was inspired by previous methods [12][13] and modified for the additional display tracker. A small panel with a circular hole is temporarily mounted in front of the bottom LCD panel. Both the hole and the bottom LCD monitor are pre-calibrated (one-time only) to the Planar's tracker with the Certus calibration stylus. The eye calibration program shows a circular disk on the display. Using a “mirror image” of the user's head as a guide, the user moves and orients his head to line up the disk through the hole, twice through each eye, under different head orientations. To avoid confusion, users wear frames with one eye masked off, as shown by the “mirror” guides at the top of FIG. 10. The program collects four line equations in head tracker coordinates. In pairs of two, these four lines define the eye centers at their intersections—or rather, at the closest points between them. The entire task takes 1-2 minutes except for inexperienced first-time users, which take longer mostly because they must receive and follow instructions.


Since the current head band tracker (FIG. 9) does not guarantee repeatable positioning on the user's head, the user should not remove it between calibration and the following interactive phase (i.e., using the system to guide an ablation). User-specific head-conforming gear equipped with IR LEDs—or with passive markers for camera-based head tracking—could eliminate this restriction and could thus reduce each user's eye calibration to a one-time procedure.


Application of Eye Calibration to Image Guided Ablation


As stated above, the user's head or eyes can be tracked during image guided ablation and the combined display shown by the rendering and display module 412 can adjust the combined display of the treatment volume based on the current position of the user's head and/or eyes. For example, in the images illustrated in FIG. 5, as the user is conducting an RFA procedure, the display illustrated in FIG. 5 may be continually updated based on the viewpoint of the user. As the user's head moves during treatment, the viewpoint of the display will be updated. FIG. 11 shows the stereoscopic display (in this case depicting a photorealistic human head) as seen by a head-tracked user moving around it. Note that the user is able to naturally look around the subject (“head-motion parallax”) as if the display contained actual three-dimensional structures. Together with stereoscopic rendering and exact eye calibration, the illusion is almost perfect.


Exact eye calibration in an ablation procedure can be used to produce the same 3D effect illustrated in FIG. 11 in the combined image displayed by rendering and display module 412 as the user moves about display 410. For example, the exact eye calibration method described herein is used to determine whether the user's eyes are with respect to headband 406, which is tracked. When the user moves about display 410, rendering and display module 412 uses the position data from headband 406 and the offset for each eye produced during eye calibration to determine the positions of each of the user's eyes. Rendering and display module 412 produces left and right eye images based on the tracked position of headband and the eye calibration data. The left and right eye images appear as a single image on display 412 because the user wears stereoscopic glasses. An example of such a combined image viewed through stereoscopic glasses is shown in FIG. 5 (right).


According to another aspect of the subject matter described herein, rendering and display module 412 may render preoperative data, including an anatomical context for the ablation of the target volume. For example, rendering and display module 412 may render organs or anatomical structures such as bones or blood vessels adjacent to the target volume. FIG. 12 illustrates an example of such a context.


The disclosure of each of the following references is hereby incorporated herein by reference in its entirety.


REFERENCES



  • [1] O. Catalano et al. “Multiphase helical CT findings after percutaneous ablation procedures for hepatocellular carcinoma.” Abdom. Imaging, 25(6), 2000, pp. 607-614.

  • [2] Michael Deering. “High Resolution Virtual Reality.” Proceedings of SIGGRAPH '92, Computer Graphics, 26 (2), 1992, pp. 195-202.

  • [3] G. D. Dodd et al. “Minimally invasive treatment of malignant hepatic tumors: at the threshold of a major breakthrough.” Radiographics 20(1), 2000, pp. 9-27.

  • [4] http://www.planar.com/products/flatpanel_monitors/stereoscopic/

  • [5] Michael Rosenthal, Andrei State, Joohi Lee, Gentaro Hirota, Jeremy Ackerman, Kurtis Keller, Etta D. Pisano, Michael Jiroutek, Keith Muller and Henry Fuchs. “Augmented reality guidance for needle biopsies: An initial randomized, controlled trial in phantoms.” Medical Image Analysis 6(3), September 2002, pp. 313-320.

  • [6] Andrei State, Kurtis P. Keller, Henry Fuchs. “Simulation-Based Design and Rapid Prototyping of a Parallax-Free, Orthoscopic Video See-Through Head-Mounted Display.” Proc. International Symposium on Mixed & Augmented Reality 2005 (Vienna, Austria, Oct. 5-8, 2005), pp. 28-31.

  • [7] Andrei State. “Exact Eye Contact with Virtual Humans.” Proc. IEEE International Workshop on Human Computer Interaction 2007 (Rio de Janeiro, Brazil, Oct. 20, 2007), pp. 138-145.

  • [8] Meehan, M., Razzaque, S., Whitton, M., Brooks, F.: Effects of Latency on Presence in Stressful Virtual Environments. Proceedings of IEEE Virtual Reality 2003, IEEE Computer Society, 141-148 (2003).

  • [9] Rolland, J. P., Burbeck, C. A., Gibson, W., Ariely, D.: Towards Quantifying Depth and Size Perception in 3D Virtual Environments. Presence: Teleoperators and Virtual Environments 4(1), 24-48 (1995).

  • [10] Holloway, R.: Registration Error Analysis for Augmented Reality. Presence: Teleoperators and Virtual Environments 6(4), 413-432 (1997).

  • [11] Lipton, L.: Foundations of the Stereoscopic Cinema. Van Nostrand Reinhold (1982).

  • [12] Azuma, R., Bishop, G.: Improving Static and Dynamic Registration in an Optical See-Through HMD. Proceedings of SIGGRAPH '94, Computer Graphics, Annual Conference Series, 1994, 197-204 (1994).

  • [13] Fuhrmann, A., Splechtna, R., Pikryl, J.: Comprehensive calibration and registration procedures for augmented reality. Proc. Eurographics Workshop on Virtual Environments 2001, 219-228 (2001).

  • [14] Raij, A. B., Johnsen, K., Dickerson, R. F., Lok, B. C., Cohen, M. S., Duerson, M., Pauly, R. R., Stevens, A. O., Wagner, P., Lind, D. S.: Comparing Interpersonal Interactions with a Virtual Human to Those with a Real Human. IEEE Transactions on Visualization and Computer Graphics 13(3), 443-457 (2007).

  • [15] Billinghurst, M., Henrysson, A.: Research Directions in Handheld AR. Int. J. of Virtual Reality 5(2), 51-58 (2006).



Although the examples described above relate primarily to RFA, the subject matter described herein is not limited to image guided RFA. The image guided techniques and systems described herein can be used with any type of ablation, including microwave ablation and cryo-ablation. In microwave ablation, a needle delivers microwave energy to the target volume. In cryo-ablation, a needle delivers cold fluid to the target volume. The tracking, rendering, and display techniques and systems described above can be used to track, render, and display microwave and cryo-ablation needles in the same manner described above. In addition, the techniques and systems described above for displaying predicted ablation volumes and ablated volumes for successive ablation passes can be applied to microwave and cryo-ablation probes by configuring rendering and display module 412 with manufacturer's specifications for these types of probes.


It will be understood that various details of the subject matter described herein may be changed without departing from the scope of the subject matter described herein. Furthermore, the foregoing description is for the purpose of illustration only, and not for the purpose of limitation, as the subject matter described herein is defined by the claims as set forth hereinafter.

Claims
  • 1. A system for image guided ablation, the system comprising: an ultrasound transducer configured to produce a real-time 2D ultrasound image slice of a target volume and surrounding tissue;an ablation probe configured to ablate the target volume;a display configured to display an image to guide positioning of the ablation probe during ablation of the target volume;at least one tracker configured to track orientations of the ablation probe, the ultrasound transducer, and a user's head during the ablation of the target volume, wherein the at least one tracker is distinct from the display; anda rendering and display module configured to: receive a 3D pre-ablation-treatment image of the target volume;receive the real-time 2D ultrasound image slice from the ultrasound transducer;receive data regarding the tracked orientation of the ablation probe, the ultrasound transducer, and the user's head produced by the at least one tracker;determine a perspective view of the 3D pre-ablation-treatment image in a virtual 3D space based at least in part on the tracked orientation of the user's head;determine a perspective view of the real-time 2D ultrasound image slice in the virtual 3D space based at least in part on the tracked orientations of the ultrasound transducer and the user's head;determine a perspective view of a virtual 3D ablation probe in the virtual 3D space based at least in part on the tracked orientations of the ablation probe and the user's head, wherein the virtual 3D ablation probe corresponds to the ablation probe;determine a perspective view of a virtual 3D ultrasound transducer in the virtual 3D space based at least in part on the tracked orientations of the ultrasound transducer and the user's head, wherein the virtual 3D ultrasound transducer corresponds to the ultrasound transducer;cause the display to simultaneously and continuously display the perspective view of the 3D pre-ablation-treatment image, the perspective view of the real-time 2D ultrasound image slice, the perspective view of the virtual 3D ablation probe, and the perspective view of the virtual 3D ultrasound transducer in the virtual 3D space based at least in part on a location of the ultrasound transducer and the ablation probe;subtract from the perspective view of the 3D pre-ablation-treatment image a volume affected by a pass of the ablation probe over a portion of the target volume, wherein the volume affected by the pass of the ablation probe over the portion of the target volume is determined based on a tracked position of the ablation probe at a time of the pass of the ablation probe over the portion of the target volume, a geometry of the ablation probe, and a power setting of the ablation probe at the time of the pass of the ablation probe over the portion of the target volume; andcause the display to display, for a momentary position of the probe, relative amounts of healthy and tumor tissue that would be affected by an ablation pass.
  • 2. The system of claim 1, wherein the ablation probe comprises at least one of: a radio frequency ablation (RFA) probe, a microwave ablation probe, or a cryo-ablation probe.
  • 3. The system of claim 1, wherein the rendering and display module is further configured to: receive eye calibration data indicating positions of the user's left and right eyes with respect to a tracked position and the tracked orientation of the user's head; andcause the display to display a stereoscopic image with left and right eye images generated based at least in part on the eye calibration data and the tracked position and orientation of the user's head.
  • 4. The system of claim 1, wherein the perspective view of the virtual 3D ablation probe in the virtual 3D space maintains a parallel orientation with respect to the ablation probe at least during the ablation of the target volume.
  • 5. The system of claim 1, wherein the rendering and display module is further configured to render pre-operative data including an anatomical context for the ablation of the target volume.
  • 6. The system of claim 1, wherein the rendering and display module is further configured to render and cause the display to display a volume that will be affected by an ablation pass for a current position and orientation of the ablation probe and for its operational specifications.
  • 7. The system of claim 1, wherein the rendering and display module is further configured to render guidance graphics including schematic 3D structures to emphasize a spatial relationship of the real-time 2D ultrasound image slice and the ablation probe.
  • 8. The system of claim 1, wherein the rendering and display module is further configured to cause the display to display the perspective view of the real-time 2D ultrasound image slice and the perspective view of the virtual 3D ablation probe in one of: a centered mode in which the real-time 2D ultrasound image slice is always shown in the center of the display, wherein it is not possible to move the ultrasound transducer such that the perspective view of the virtual 3D ultrasound transducer is not displayed on the display; anda free mode in which the user can interactively define a position offset between an area within a patient and the virtual 3D space of the display, wherein translational motion of the ablation probe and the ultrasound transducer results in translational motion of the perspective view of the virtual 3D ablation probe and the perspective view of the virtual 3D ultrasound transducer in the virtual 3D space, and wherein it is possible to move the ultrasound transducer such that the perspective view of the virtual 3D ultrasound transducer is not displayed on the display.
  • 9. The system of claim 1, further comprising a tine deployment tracker configured to track deployment of tines of the ablation probe and to provide tine deployment tracking data to the rendering and display module, wherein the rendering and display module is further configured to cause the display to display ablation probe tine deployment.
  • 10. A method for producing an image suitable for image guided ablation, the method comprising: receiving a real-time 2D ultrasound image slice of a target volume and surrounding tissue from an ultrasound transducer;receiving a 3D pre-ablation image of the target volume;tracking, using at least one tracker, orientations of an ablation probe, the ultrasound transducer, and a user's head during ablation of the target volume;determining a perspective view of the 3D pre-ablation-treatment image in a virtual 3D space based at least in part on the tracked orientation of the user's head;determining a perspective view of the real-time 2D ultrasound image slice in the virtual 3D space based at least in part on the tracked orientations of the ultrasound transducer and the user's head;determining a perspective view of a virtual 3D ablation probe in the virtual 3D space based at least in part on the tracked orientations of the ablation probe and the user's head, wherein the virtual 3D ablation probe corresponds to the ablation probe;determining a perspective view of a virtual 3D ultrasound transducer in the virtual 3D space based at least in part on the tracked orientations of the ultrasound transducer and the user's head, wherein the virtual 3D ultrasound transducer corresponds to the ultrasound transducer;causing a display to simultaneously and continuously display the perspective view of the 3D pre-ablation-treatment image, the perspective view of the real-time 2D ultrasound image slice, the perspective view of the virtual 3D ablation probe, and the perspective view of the virtual 3D ultrasound transducer in the virtual 3D space based at least in part on a location of the ultrasound transducer and the ablation probe, wherein the display is distinct from the at least one tracker;subtracting from the perspective view of the 3D pre-ablation image a volume affected by a pass of the ablation probe over a portion of the target volume, wherein the volume affected by the pass of the ablation probe over the portion of the target volume is determined based on a tracked position of the ablation probe at a time of the pass of the ablation probe over the portion of the target volume, a geometry of the ablation probe, and a power setting of the ablation probe at the time of the pass of the ablation probe over the portion of the target volume; andcausing the display to display, for a momentary position of the probe, relative amounts of healthy and tumor tissue that would be affected by an ablation pass.
  • 11. The method of claim 10, wherein the ablation probe comprises one of: a radio frequency ablation (RFA) probe, a microwave ablation probe, and a cryoablation probe.
  • 12. The method of claim 10, further comprising: receiving eye calibration data regarding positions of a user's left and right eyes; andcausing the display to display a stereoscopic image including left and right eye images generated based at least in part the eye calibration data and a tracked position and the tracked orientation of the user's head.
  • 13. The method of claim 10, wherein the perspective view of the virtual 3D ultrasound transducer and the perspective view of the virtual 3D ablation probe maintain a parallel orientation with respect to the ultrasound transducer and the ablation probe, respectively, at least during guidance of the ablation probe to the target volume and during the ablation of the target volume.
  • 14. The method of claim 10, further comprising rendering preoperative data including an anatomical context for the ablation of the target volume.
  • 15. The method of claim 10, further comprising rendering and causing the display to display a predicted treatment volume for a current position and orientation of the ablation probe and for its operational specifications.
  • 16. The method of claim 10, further comprising rendering guidance graphics including schematic 3D structures to emphasize a spatial relationship between the real-time 2D ultrasound image slice and the ablation probe.
  • 17. The method of claim 10, further comprising causing the display to display the perspective view of the real-time 2D ultrasound image slice and the perspective view of the virtual 3D ablation probe in one of the following modes: a centered mode in which the real-time 2D ultrasound image slice is always shown in the center of the display, wherein it is not possible to move the ultrasound transducer such that the perspective view of the virtual 3D ultrasound transducer is not displayed on the display;a free mode in which the user can interactively define a position offset between an area within a patient and the virtual 3D space of the display, wherein translational motion of the ablation probe and the ultrasound transducer results in translational motion of the perspective view of the virtual 3D ablation probe and the perspective view of the virtual 3D ultrasound transducer in the virtual 3D space, and wherein it is possible to move the ultrasound transducer such that the perspective view of the virtual 3D ultrasound transducer is not displayed on the display.
  • 18. The method of claim 10, further comprising: tracking deployment of tines of the ablation probe; andcausing the display to display a position of the tines of the ablation probe in the virtual 3D space.
  • 19. A non-transitory computer readable medium having stored thereon executable instructions that when executed by a processor of a computer perform steps, the steps comprising: receiving a real-time 2D ultrasound image slice of a target volume and surrounding tissue from an ultrasound transducer;receiving a 3D pre-ablation image of the target volume;tracking, using at least one tracker, orientations of an ablation probe, the ultrasound transducer, and a user's head during ablation of the target volume;determining a perspective view of the 3D pre-ablation-treatment image in a virtual 3D space based at least in part on the tracked orientation of the user's head;determining a perspective view of the real-time 2D ultrasound image slice in the virtual 3D space based at least in part on the tracked orientations of the ultrasound transducer and the user's head;determining a perspective view of a virtual 3D ablation probe in the virtual 3D space based at least in part on the tracked orientations of the ablation probe and the user's head, wherein the virtual 3D ablation probe corresponds to the ablation probe;determining a perspective view of a virtual 3D ultrasound transducer in the virtual 3D space based at least in part on the tracked orientations of the ultrasound transducer and the user's head, wherein the virtual 3D ultrasound transducer corresponds to the ultrasound transducer;causing a display to simultaneously and continuously display the perspective view of the 3D pre-ablation-treatment image, the perspective view of the real-time 2D ultrasound image slice, the perspective view of the virtual 3D ablation probe, and the perspective view of the virtual 3D ultrasound transducer in the virtual 3D space based at least in part on a location of the ultrasound transducer and the ablation probe;subtracting from the perspective view of the 3D pre-ablation image a volume affected by a pass of the ablation probe over a portion of the target volume, wherein the volume affected by the pass of the ablation probe over the portion of the target volume is determined based on a tracked position of the ablation probe at a time of the pass of the ablation probe over the portion of the target volume, a geometry of the ablation probe, and a power setting of the ablation probe at the time of the pass of the ablation probe over the portion of the target volume; andcausing the display to display, for a momentary position of the probe, relative amounts of healthy and tumor tissue that would be affected by an ablation pass.
  • 20. The system of claim 1, wherein the perspective view of the real-time 2D ultrasound image slice and the perspective view of the virtual 3D ultrasound transducer are displayed in the virtual 3D space when the ultrasound transducer is located within a predetermined area and the perspective view of the real-time 2D ultrasound image slice and the perspective view of the virtual 3D ultrasound transducer are not displayed in the virtual 3D space when the ultrasound transducer is located outside the predetermined area.
  • 21. The system of claim 1, wherein the perspective view of the virtual 3D ablation probe is displayed in the virtual 3D space when the ablation probe is located within a predetermined area and the perspective view of the virtual 3D ablation probe is not displayed in the virtual 3D space when the ablation probe is located outside the predetermined area.
RELATED APPLICATIONS

This application is a continuation of PCT International Patent Application No. PCT/US2009/032028, filed Jan. 26, 2009, which claims the benefit of U.S. Provisional Patent Application Ser. No. 61/023,268, filed Jan. 24, 2008; the disclosures of each which are incorporated herein by reference in their entireties.

GOVERNMENT INTEREST

This presently disclosed subject matter was made with U.S. Government support under Grant No. 1-R01-CA101186-01A2 awarded by the National Institutes of Health. Thus, the U.S. Government has certain rights in the presently disclosed subject matter.

US Referenced Citations (402)
Number Name Date Kind
3556079 Omizo Jan 1971 A
4058114 Soldner Nov 1977 A
RE30397 King Sep 1980 E
4249539 Vilkomerson et al. Feb 1981 A
4294544 Altschuler et al. Oct 1981 A
4390025 Takemura et al. Jun 1983 A
4407294 Vilkomerso Oct 1983 A
4431006 Trimmer et al. Feb 1984 A
4567896 Barnea et al. Feb 1986 A
4583538 Onik et al. Apr 1986 A
4620546 Aida et al. Nov 1986 A
4671292 Matzuk Jun 1987 A
4839836 Fonsalas Jun 1989 A
4862873 Yajima et al. Sep 1989 A
4884219 Waldren Nov 1989 A
4899756 Sonek Feb 1990 A
4911173 Terwillige Mar 1990 A
4945305 Blood Jul 1990 A
5076279 Arenson et al. Dec 1991 A
5078140 Kwoh Jan 1992 A
5078142 Siczek et al. Jan 1992 A
5095910 Powers Mar 1992 A
5109276 Nudelman et al. Apr 1992 A
5158088 Nelson et al. Oct 1992 A
5161536 Vilkomerson et al. Nov 1992 A
5193120 Gamache et al. Mar 1993 A
5209235 Brisken et al. May 1993 A
5249581 Horbal et al. Oct 1993 A
5251127 Raab Oct 1993 A
5261404 Mick et al. Nov 1993 A
5265610 Darrow et al. Nov 1993 A
5271400 Dumoulin et al. Dec 1993 A
5307153 Maruyama et al. Apr 1994 A
5309913 Kormos et al. May 1994 A
5323002 Sampsell et al. Jun 1994 A
5371543 Anderson Dec 1994 A
5383454 Bucholz Jan 1995 A
5394875 Lewis et al. Mar 1995 A
5411026 Carol May 1995 A
5433198 Desai Jul 1995 A
5433739 Sluijter et al. Jul 1995 A
5443489 Ben-Haim Aug 1995 A
5446798 Morita et al. Aug 1995 A
5447154 Cinquin et al. Sep 1995 A
5452024 Sampsell Sep 1995 A
5457493 Leddy et al. Oct 1995 A
5474073 Schwartz et al. Dec 1995 A
5476096 Olstad et al. Dec 1995 A
5483961 Kelly et al. Jan 1996 A
5488431 Gove et al. Jan 1996 A
5489952 Gove et al. Feb 1996 A
5491510 Gove Feb 1996 A
5494039 Onik et al. Feb 1996 A
5503152 Oakley et al. Apr 1996 A
5505204 Picot et al. Apr 1996 A
5515856 Olstad et al. May 1996 A
5517990 Kalfas et al. May 1996 A
5526051 Gove et al. Jun 1996 A
5526812 Dumoulin et al. Jun 1996 A
5529070 Augustine et al. Jun 1996 A
5531227 Schneider Jul 1996 A
5532997 Pauli Jul 1996 A
5541723 Tanaka Jul 1996 A
5558091 Acker et al. Sep 1996 A
5568811 Olstad Oct 1996 A
5570135 Gove et al. Oct 1996 A
5579026 Tabata Nov 1996 A
5581271 Kraemer Dec 1996 A
5588948 Takahashi et al. Dec 1996 A
5608468 Gove et al. Mar 1997 A
5608849 King, Jr. Mar 1997 A
5611345 Hibbeln Mar 1997 A
5611353 Dance et al. Mar 1997 A
5612753 Poradish et al. Mar 1997 A
5625408 Matsugu et al. Apr 1997 A
5628327 Unger et al. May 1997 A
5629794 Magel et al. May 1997 A
5630027 Venkateswar et al. May 1997 A
5647361 Damadian Jul 1997 A
5647373 Paltieli Jul 1997 A
5660185 Shmulewitz et al. Aug 1997 A
5662111 Cosman Sep 1997 A
5699444 Palm Dec 1997 A
5701898 Adam et al. Dec 1997 A
5701900 Shehada et al. Dec 1997 A
5726670 Tabata et al. Mar 1998 A
5728044 Shan Mar 1998 A
5758650 Miller et al. Jun 1998 A
5766135 Terwilliger Jun 1998 A
5784098 Shoji et al. Jul 1998 A
5792147 Evans et al. Aug 1998 A
5793701 Wright et al. Aug 1998 A
5797849 Vesely et al. Aug 1998 A
5807395 Mulier et al. Sep 1998 A
5810008 Dekel et al. Sep 1998 A
5817022 Vesely Oct 1998 A
5820554 Davis et al. Oct 1998 A
5820561 Olstad et al. Oct 1998 A
5829439 Yokosawa et al. Nov 1998 A
5829444 Ferre et al. Nov 1998 A
5851183 Bucholz Dec 1998 A
5870136 Fuchs et al. Feb 1999 A
5891034 Bucholz Apr 1999 A
5920395 Schulz Jul 1999 A
5961527 Whitmore, III et al. Oct 1999 A
5967980 Ferre et al. Oct 1999 A
5991085 Rallison et al. Nov 1999 A
6016439 Acker Jan 2000 A
6019724 Gronningsaeter et al. Feb 2000 A
6048312 Ishrak et al. Apr 2000 A
6064749 Hirota et al. May 2000 A
6091546 Spitzer Jul 2000 A
6095982 Richards-Kortum et al. Aug 2000 A
6099471 Torp et al. Aug 2000 A
6108130 Raj Aug 2000 A
6122538 Sliwa, Jr. et al. Sep 2000 A
6122541 Cosman et al. Sep 2000 A
6160666 Rallison et al. Dec 2000 A
6167296 Shahidi Dec 2000 A
6181371 Maguire, Jr. Jan 2001 B1
RE37088 Olstad et al. Mar 2001 E
6216029 Paltieli Apr 2001 B1
6241725 Cosman Jun 2001 B1
6245017 Hashimoto et al. Jun 2001 B1
6246898 Vesely et al. Jun 2001 B1
6248101 Witmore, III et al. Jun 2001 B1
6261234 Lin Jul 2001 B1
6341016 Malione Jan 2002 B1
6348058 Melken et al. Feb 2002 B1
6350238 Olstad et al. Feb 2002 B1
6352507 Torp et al. Mar 2002 B1
6379302 Kessman et al. Apr 2002 B1
6385475 Cinquin et al. May 2002 B1
6442417 Shahidi et al. Aug 2002 B1
6447450 Olstad Sep 2002 B1
6456868 Saito et al. Sep 2002 B2
6470207 Simon et al. Oct 2002 B1
6471366 Hughson et al. Oct 2002 B1
6477400 Barrick Nov 2002 B1
6478793 Cosman et al. Nov 2002 B1
6503195 Keller et al. Jan 2003 B1
6511418 Shahidi et al. Jan 2003 B2
6517485 Torp et al. Feb 2003 B2
6518939 Kikuchi Feb 2003 B1
6527443 Vilsmeier Mar 2003 B1
6529758 Shahidi Mar 2003 B2
6537217 Bjaerum et al. Mar 2003 B1
6545706 Edwards et al. Apr 2003 B1
6546279 Bova et al. Apr 2003 B1
6551325 Neubauer et al. Apr 2003 B2
6570566 Yoshigahara May 2003 B1
6575969 Rittman et al. Jun 2003 B1
6579240 Bjaerum et al. Jun 2003 B2
6587711 Alfano et al. Jul 2003 B1
6591130 Shahidi Jul 2003 B2
6592522 Bjaerum et al. Jul 2003 B2
6594517 Nevo Jul 2003 B1
6597818 Kumar et al. Jul 2003 B2
6604404 Paltieli et al. Aug 2003 B2
6616610 Steininger et al. Sep 2003 B2
6626832 Paltieli et al. Sep 2003 B1
6652462 Bjaerum et al. Nov 2003 B2
6669635 Kessman et al. Dec 2003 B2
6676599 Torp et al. Jan 2004 B2
6689067 Sauer et al. Feb 2004 B2
6695786 Wang et al. Feb 2004 B2
6711429 Gilboa et al. Mar 2004 B1
6725082 Sati et al. Apr 2004 B2
6733458 Steins et al. May 2004 B1
6764449 Lee et al. Jul 2004 B2
6766184 Utzinger et al. Jul 2004 B2
6768496 Bieger et al. Jul 2004 B2
6775404 Pagoulatos et al. Aug 2004 B1
6782287 Grzeszczuk et al. Aug 2004 B2
6783524 Anderson et al. Aug 2004 B2
6827723 Carson Dec 2004 B2
6863655 Bjaerum et al. Mar 2005 B2
6873867 Vilsmeier Mar 2005 B2
6875179 Ferguson et al. Apr 2005 B2
6881214 Cosman et al. Apr 2005 B2
6895268 Rahn et al. May 2005 B1
6915150 Cinquin et al. Jul 2005 B2
6917827 Kienzle, III Jul 2005 B2
6923817 Carson et al. Aug 2005 B2
6936048 Hurst Aug 2005 B2
6947783 Immerz Sep 2005 B2
6968224 Kessman et al. Nov 2005 B2
6978167 Dekel et al. Dec 2005 B2
7008373 Stoianovici et al. Mar 2006 B2
7033360 Cinquin et al. Apr 2006 B2
7072707 Galloway, Jr. et al. Jul 2006 B2
7077807 Torp et al. Jul 2006 B2
7093012 Olstad et al. Aug 2006 B2
7110013 Ebersole et al. Sep 2006 B2
7171255 Holupka et al. Jan 2007 B2
7209776 Leitner Apr 2007 B2
7245746 Bjaerum et al. Jul 2007 B2
7248232 Yamazaki et al. Jul 2007 B1
7261694 Torp et al. Aug 2007 B2
7313430 Urquhart et al. Dec 2007 B2
7331932 Leitner Feb 2008 B2
7351205 Szczech et al. Apr 2008 B2
7379769 Piron et al. May 2008 B2
7385708 Ackerman et al. Jun 2008 B2
7392076 Moctezuma de la Barrera Jun 2008 B2
7398116 Edwards Jul 2008 B2
7466303 Yi et al. Dec 2008 B2
7480533 Cosman et al. Jan 2009 B2
7505809 Strommer et al. Mar 2009 B2
7588541 Floyd et al. Sep 2009 B2
7652259 Kimchy et al. Jan 2010 B2
7662128 Salcudean et al. Feb 2010 B2
7678052 Torp et al. Mar 2010 B2
7728868 Razzaque et al. Jun 2010 B2
7797032 Martinelli et al. Sep 2010 B2
7798965 Torp et al. Sep 2010 B2
7833168 Taylor et al. Nov 2010 B2
7833221 Voegele et al. Nov 2010 B2
7846103 Cannon, Jr. et al. Dec 2010 B2
7876942 Gilboa Jan 2011 B2
7889905 Higgins et al. Feb 2011 B2
7912849 Ohrn et al. Mar 2011 B2
7920909 Lyon et al. Apr 2011 B2
7962193 Edwards et al. Jun 2011 B2
7976469 Bonde et al. Jul 2011 B2
8023712 Ikuma et al. Sep 2011 B2
8038631 Sanghvi et al. Oct 2011 B1
8041413 Barbagli et al. Oct 2011 B2
8050736 Piron et al. Nov 2011 B2
8052636 Moll et al. Nov 2011 B2
8066644 Sarkar et al. Nov 2011 B2
8073528 Zhao et al. Dec 2011 B2
8086298 Whitmore, III et al. Dec 2011 B2
8135669 Olstad et al. Mar 2012 B2
8137281 Huang et al. Mar 2012 B2
8147408 Bunce et al. Apr 2012 B2
8152724 Ridley et al. Apr 2012 B2
8167805 Emery et al. May 2012 B2
8216149 Oonuki et al. Jul 2012 B2
8221322 Wang et al. Jul 2012 B2
8228028 Schneider Jul 2012 B2
8257264 Park et al. Sep 2012 B2
8296797 Olstad et al. Oct 2012 B2
8340379 Razzaque et al. Dec 2012 B2
8350902 Razzaque et al. Jan 2013 B2
8482606 Razzaque et al. Jul 2013 B2
8554307 Razzaque et al. Oct 2013 B2
8585598 Razzaque et al. Nov 2013 B2
8641621 Razzaque et al. Feb 2014 B2
8670816 Green et al. Mar 2014 B2
8690776 Razzaque et al. Apr 2014 B2
8831310 Razzaque et al. Sep 2014 B2
20010007919 Shahidi Jul 2001 A1
20010016804 Cunningham et al. Aug 2001 A1
20010041838 Holupka et al. Nov 2001 A1
20010045979 Matsumoto et al. Nov 2001 A1
20020010384 Shahidi et al. Jan 2002 A1
20020032772 Olstad et al. Mar 2002 A1
20020049375 Strommer et al. Apr 2002 A1
20020077540 Kienzle, III Jun 2002 A1
20020077543 Grzeszczuk et al. Jun 2002 A1
20020105484 Navab et al. Aug 2002 A1
20020135673 Favalora et al. Sep 2002 A1
20020138008 Tsujita et al. Sep 2002 A1
20020140814 Cohen-Solal et al. Oct 2002 A1
20020156375 Kessman et al. Oct 2002 A1
20020198451 Carson Dec 2002 A1
20030040743 Cosman et al. Feb 2003 A1
20030073901 Simon et al. Apr 2003 A1
20030135119 Lee et al. Jul 2003 A1
20030163142 Paltieli et al. Aug 2003 A1
20030164172 Chumas et al. Sep 2003 A1
20030231789 Willis et al. Dec 2003 A1
20040034313 Leitner Feb 2004 A1
20040078036 Keidar Apr 2004 A1
20040095507 Bishop et al. May 2004 A1
20040116810 Olstad Jun 2004 A1
20040147920 Keidar Jul 2004 A1
20040152970 Hunter et al. Aug 2004 A1
20040181144 Cinquin et al. Sep 2004 A1
20040215071 Frank et al. Oct 2004 A1
20040238732 State et al. Dec 2004 A1
20040243146 Chesbrough et al. Dec 2004 A1
20040243148 Wasielewski Dec 2004 A1
20040249281 Olstad Dec 2004 A1
20040249282 Olstad Dec 2004 A1
20040254454 Kockro Dec 2004 A1
20050010098 Frigstad et al. Jan 2005 A1
20050085717 Shahidi Apr 2005 A1
20050085718 Shahidi Apr 2005 A1
20050090742 Mine et al. Apr 2005 A1
20050111733 Fors et al. May 2005 A1
20050159641 Kanai Jul 2005 A1
20050182316 Burdette et al. Aug 2005 A1
20050192564 Cosman et al. Sep 2005 A1
20050219552 Ackerman et al. Oct 2005 A1
20050222574 Giordano et al. Oct 2005 A1
20050251148 Friedrich Nov 2005 A1
20060004275 Vija et al. Jan 2006 A1
20060020204 Serra et al. Jan 2006 A1
20060036162 Shahidi et al. Feb 2006 A1
20060052792 Boettiger et al. Mar 2006 A1
20060058609 Olstad Mar 2006 A1
20060058610 Olstad Mar 2006 A1
20060058674 Olstad Mar 2006 A1
20060058675 Olstad Mar 2006 A1
20060100505 Viswanathan May 2006 A1
20060122495 Kienzle, III Jun 2006 A1
20060184040 Keller et al. Aug 2006 A1
20060193504 Salgo et al. Aug 2006 A1
20060229594 Francischelli et al. Oct 2006 A1
20060235290 Gabriel et al. Oct 2006 A1
20060235538 Rochetin et al. Oct 2006 A1
20060241450 Da Silva et al. Oct 2006 A1
20060253030 Altmann et al. Nov 2006 A1
20060253032 Altmann et al. Nov 2006 A1
20060271056 Terrill-Grisoni et al. Nov 2006 A1
20060282023 Leitner Dec 2006 A1
20060293643 Wallace et al. Dec 2006 A1
20070016035 Hashimoto Jan 2007 A1
20070032906 Sutherland et al. Feb 2007 A1
20070073155 Park et al. Mar 2007 A1
20070078346 Park et al. Apr 2007 A1
20070167699 Lathuiliere et al. Jul 2007 A1
20070167701 Sherman Jul 2007 A1
20070167705 Chiang et al. Jul 2007 A1
20070167771 Olstad Jul 2007 A1
20070167801 Webler et al. Jul 2007 A1
20070225553 Shahidi Sep 2007 A1
20070239281 Gotte et al. Oct 2007 A1
20070244488 Metzger et al. Oct 2007 A1
20070255136 Kristofferson et al. Nov 2007 A1
20070270718 Rochetin et al. Nov 2007 A1
20070276234 Shahidi Nov 2007 A1
20080004481 Bax et al. Jan 2008 A1
20080004516 DiSilvestro et al. Jan 2008 A1
20080030578 Razzaque et al. Feb 2008 A1
20080039723 Suri et al. Feb 2008 A1
20080051910 Kammerzell et al. Feb 2008 A1
20080091106 Kim et al. Apr 2008 A1
20080114235 Unal et al. May 2008 A1
20080161824 McMillen Jul 2008 A1
20080200794 Teichman et al. Aug 2008 A1
20080208031 Kurpad et al. Aug 2008 A1
20080208081 Murphy et al. Aug 2008 A1
20080214932 Mollard et al. Sep 2008 A1
20080232679 Hahn et al. Sep 2008 A1
20080287794 Li et al. Nov 2008 A1
20080287805 Li Nov 2008 A1
20080287837 Makin et al. Nov 2008 A1
20090024030 Lachaine et al. Jan 2009 A1
20090118724 Zvuloni et al. May 2009 A1
20090137907 Takimoto et al. May 2009 A1
20090226069 Razzaque et al. Sep 2009 A1
20090234369 Bax et al. Sep 2009 A1
20090312629 Razzaque et al. Dec 2009 A1
20100045783 State et al. Feb 2010 A1
20100198045 Razzaque et al. Aug 2010 A1
20100208963 Kruecker et al. Aug 2010 A1
20100268072 Hall et al. Oct 2010 A1
20100268085 Kruecker et al. Oct 2010 A1
20100305448 Dagonneau et al. Dec 2010 A1
20100312121 Guan Dec 2010 A1
20100331252 Hamrick Dec 2010 A1
20110043612 Keller et al. Feb 2011 A1
20110046483 Fuchs et al. Feb 2011 A1
20110057930 Keller et al. Mar 2011 A1
20110082351 Razzaque et al. Apr 2011 A1
20110130641 Razzaque et al. Jun 2011 A1
20110137156 Razzaque et al. Jun 2011 A1
20110201915 Gogin et al. Aug 2011 A1
20110201976 Sanghvi et al. Aug 2011 A1
20110230351 Fischer et al. Sep 2011 A1
20110237947 Boctor et al. Sep 2011 A1
20110238043 Kleven Sep 2011 A1
20110251483 Razzaque et al. Oct 2011 A1
20110274324 Clements et al. Nov 2011 A1
20110282188 Burnside et al. Nov 2011 A1
20110288412 Deckman et al. Nov 2011 A1
20110295108 Cox et al. Dec 2011 A1
20110301451 Rohling Dec 2011 A1
20120035473 Sanghvi et al. Feb 2012 A1
20120059260 Robinson Mar 2012 A1
20120071759 Hagy et al. Mar 2012 A1
20120078094 Nishina et al. Mar 2012 A1
20120101370 Razzaque et al. Apr 2012 A1
20120108955 Razzaque et al. May 2012 A1
20120143029 Silverstein et al. Jun 2012 A1
20120143055 Ng et al. Jun 2012 A1
20120165679 Orome et al. Jun 2012 A1
20120259210 Harhen et al. Oct 2012 A1
20130030286 Alouani et al. Jan 2013 A1
20130044930 Li et al. Feb 2013 A1
20130079770 Kyle, Jr. et al. Mar 2013 A1
20130129175 Razzaque et al. May 2013 A1
20130132374 Olstad et al. May 2013 A1
20130151533 Udupa et al. Jun 2013 A1
20130178745 Kyle, Jr. et al. Jul 2013 A1
20140016848 Razzaque et al. Jan 2014 A1
20140078138 Martin et al. Mar 2014 A1
20140094687 Razzaque Apr 2014 A1
20140180074 Green et al. Jun 2014 A1
Foreign Referenced Citations (36)
Number Date Country
7656896 May 1997 AU
9453898 Apr 1999 AU
1719601 Jun 2001 AU
9036301 Mar 2002 AU
2003297225 Jul 2004 AU
2001290363 Feb 2006 AU
0113882 Jul 2003 BR
2420382 Apr 2011 CA
60126798 Oct 2007 DE
0 427 358 May 1991 EP
1955284 Aug 2008 EP
S63-290550 Nov 1988 JP
H07-116164 May 1995 JP
2005-058584 Mar 2005 JP
2005-323669 Nov 2005 JP
2009-517177 Apr 2009 JP
WO 9605768 Feb 1996 WO
WO 9715249 May 1997 WO
WO 9717014 May 1997 WO
WO 9926534 Jun 1999 WO
WO 0139683 Jun 2001 WO
WO 03032837 Apr 2003 WO
WO 03034705 Apr 2003 WO
WO 03105289 Dec 2003 WO
WO 2005010711 Feb 2005 WO
WO 2007019216 Feb 2007 WO
WO 2007067323 Jun 2007 WO
WO 2007-067323 Sep 2007 WO
WO 2008017051 Feb 2008 WO
WO 2009063423 May 2009 WO
WO 2009094646 Jul 2009 WO
WO 2010057315 May 2010 WO
WO 2010-096419 Aug 2010 WO
WO 2011014687 Feb 2011 WO
WO 2012169990 Dec 2012 WO
WO 2013116240 Aug 2013 WO
Non-Patent Literature Citations (125)
Entry
International Search Report for International Application No. PCT/US2009/032028 (Sep. 9, 2009).
“3D Laparoscope,” copyright 2007 InnerOptic Technology, Inc. 2 pages.
“Cancer Facts & Figures 2004,” www.cancer.org/downloads/STT/CAFF—finalPWSecured.pdf, copyright 2004 American Cancer Society, Inc., printed Sep. 19, 2007, 60 pages.
“David Laserscanner <-Latest News <-Institute for Robotics and Process Control <-Te . . . ,” http://www/rob.cs.tu-bs.de/en/news/david, printed Sep. 19, 2007, 1 page.
“laser scanned 3d model Final” video, still image of video attached, http://www.youtube.com/watch?v+DaLglgmoUf8, copyright 2007 YouTube, LLC, printed Sep. 19, 2007, 2 pages.
“mile robbins—Computer Vision Research—Stereo Depth Perception,” http://www.compumike.com/vision/stereodepth. php, copyright 2007 Michael F. Robbins, printed Sep. 19, 2007, 3 pages.
“Olympus Endoscopic Ultrasound System,” www.olympusamerica.com/msg—section/download—brochures/135—b—gfum130.pdf, printed Sep. 20, 2007, 20 pages.
“Point Grey Research Inc.—Imaging Products—Triclops SDK Samples,” http://www.ptgrey.com/products/triclopsSDK/ samples.asp, copyright 2007 Point Grey Research Inc., printed Sep. 19, 2007, 1 page.
“RUE: Registered Ultrasound-Endoscope,” copyright 2007 InnerOptic Technology, Inc., 2 pages.
Advertisement, “Inspeck 3DC 3D Capturor,” Inspeck 3DC 3D Capturor (www.inspeck.com), 1998.
Advertisement, “Virtual 3D High Speed Non-Contact Surface Perception,” Virtual 3-D Technologies Corporation (www.virtual3dtech.com), Dec. 21, 1998.
Advertisements, “Virtuoso,” Visual Interface, Inc. (www.visint.com), Dec. 21, 1998.
Akka, “Automatic Software Control of Display Parameters for Stereoscopic Graphics Images,” SPIE vol. 1669: Stereoscopic Displays and Applications III, pp. 31-38 (1992).
Ali et al., “Near Infrared Spectroscopy and Imaging to Probe Differences in Water Content in Normal and Cancer Human Prostate Tissues,” Technology in Cancer Research & Treatment; Oct. 2004; 3(5):491-497; Adenine Press.
Aylward et al., “Analysis of the Parameter Space of a Metric for Registering 3D Vascular Images,” in W. Niessen and M. Viergever (Eds.): MICCAI 2001, LNCS 2208, pp. 932-939, 2001.
Aylward et al., “Intra-Operative 3D Ultrasound Augmentation,” Proceedings of the IEEE International Symposium on Biomedical Imaging, Washington, Jul. 2002.
Aylward et al., “Registration and Analysis of Vascular Images,” International Journal of Computer Vision 55(2/3), pp. 123-138 (2003).
Azuma et al., “Improving Static and Dynamic Registration in an Optical See-Through HMO,” Proceedings of SIGGRAPH '94, Computer Graphics, Annual Conference Series, 1994, 197-204 (1994.
Azuma, “A Survey of Augmented Reality,” Presence: Teleoperators and Virtual Environments 6, vol. 4, pp. 1-48 (Aug. 1997).
Badler et al., “Simulating Humans: Computer Graphics, Animation, and Control,” Oxford University Press (1993).
Bajura et al., “Merging Virtual Objects with the Real World: Seeing Ultrasound Imagery within the Patient,” Computer Graphics, vol. 26, No. 2, pp. 203-210 (Jul. 1992).
Benavides et al., “Multispectral digital colposcopy for in vivo detection of cervical cancer,” Optics Express; May 19, 2003; 11(1 0) Optical Society of America; USA.
Beraldin et al., “Optimized Position Sensors for Flying-Spot Active Triangulation Systems,” Proceedings of the Fourth International Conference on a 3-D Digital Imaging and Modeling (3DIM), Banff, Alberta, Canada, Oct. 6-10, 2003, pp. 334-341, NRC 47083, National Research Council of Canada, http://iit-iti.nrc-.
Billinghurst et al.; Research Directions in Handheld AR; Int. J. of Virtual Reality 5(2), 51-58 (2006).
Blais, “Review of 20 Years of Range Sensor Development,” Journal of Electronic Imaging, 13(1): 231-240, Jan. 2004, NRC 46531, copyright 2004 National Research Council of Canada, http://iit-iti.nrc-cnrc.gc.ca/iit-publications-iti/docs/NRC-46531.pdf, printed Sep. 19, 2007, 14 pages.
Bouguet, “Camera Calibration Toolbox for Matlab,” www.vision.caltech.edu/bouguetj/calib—doc, printed Sep. 20, 2007, 5 pages.
Buxton et al.; “Colposcopically directed punch biopsy: a potentially misleading investigation,” British Journal of Obstetrics and Gynecology; Dec. 1991; 98:1273-1276.
Cancer Prevention & Early Detection Facts & Figures 2004; National Center for Tobacco-Free Kids; 2004; American Cancer Society; USA.
Cantor et al., “Cost-Effectiveness Analysis of Diagnosis and Management of Cervical Squamous Intraepithelial Lesions,” Diagnostic Strategies for SILs; Feb. 1998; 91(2):270-277.
Catalano et al. “Multiphase helical CT findings after percutaneous ablation procedures for hepatocellular carcinoma.” Abdom. Imaging, 25(6), 2000, pp. 607-614.
Chiriboga et al., “Infrared Spectroscopy of Human Tissue. IV. Detection of Dysplastic and Neoplastic Changes of Human Cervical Tissue Via Infrared Microscopy,” Cellular and Molecular Biology; 1998; 44(1):219-229.
Crawford et al., “Computer Modeling of Prostate Biopsy: Tumor Size and Location—Not Clinical Significance—Determine Cancer Detection,” Journal of Urology, Apr. 1998, vol. 159(4), pp. 1260-1264, 5 pages.
Deering, “High Resolution Virtual Reality.” Proceedings of SIGGRAPH '92, Computer Graphics, 26(2), 1992, pp. 195-202.
Depiero et al., “3-D Computer Vision Using Structured Light: Design, Calibration and Implementation Issues,” The University of Tennessee, pp. 1-46, (1996).
Dodd et al., “Minimally invasive treatment of malignant hepatic tumors: at the threshold of a major breakthrough.” Radiographies 20(1),2000, pp. 9-27.
Drascic et al., “Perceptual Issues in Augmented Reality,” SPIE vol. 2653: Stereoscopic Displays and Virtual Reality Systems III, pp. 123-134 (Feb. 1996).
Fahey et al., “Meta-analysis of Pap Test Accuracy; American Journal of Epidemiology,” 1995 141(7):680-689; The John Hopkins University School of Hvqiene and Public Health; USA.
Final Official Action for U.S. Appl. No. 10/492,582 (Apr. 30, 2009).
Foxlin et al., “An Inertial Head-Orientation Tracker with Automatic Drift Compensation for Use with HMD's,” Virtual Reality Software & Technology, Proceedings of the VRST Conference, pp. 159-173, Singapore, Aug. 23-26, 1994.
Fronheiser et al., “Real-Time 3D Color Doppler for Guidance of Vibrating Interventional Devices,” IEEE ULTRASONICS Symposium, pp. 149-152 (2004).
Fuchs et al., “Augmented Reality Visualization for Laparoscopic Surgery,” Proceedings of Medical Image Computer and Computer-Assisted Intervention, MICCAI '98, pp. 1-10 (1998).
Fuhrmann et al., “Comprehensive calibration and registration procedures for augmented reality,” Proc. Eurographics Workshop on Virtual Environments 2001,219-228 (2001).
Garrett et al., “Real-Time Incremental Visualization of Dynamic Ultrasound Volumes Using Parallel BSP Trees,”Proceedings of IEEE Visualization 1996, pp. 235-240, available from www.cs.unc.edu/˜andrei/pubs/1996 VIS dualBSP Mac.pdf, printed Sep. 20, 2007, 7 pages.
Georgakoudi et al., “Trimodal spectroscopy for the detection and characterization of cervical precancers in vivo,” American Journal of Obstetrics and Gynecology; Mar. 2002; 186(3):374-382; USA.
Herline et al., “Surface Registration for Use in Interactive, Image-Guided Liver Surgery,” Computer Aided Surgery 5:11-17 (2000).
Holloway; Registration Error Analysis for Augmented Reality; Presence: Teleoperators and Virtual Environments 6(4), 413-432 (1997).
Hornung et al., “Quantitative near-infrared spectroscopy of cervical dysplasia in vivo,” Human Reproduction; 1999; 14(11):2908-2916; European Society of Human Reproduction and Embryology.
Howard et al., An Electronic Device for Needle Placement during Sonographically Guided Percutaneous Intervention, Radiology 2001; 218:905-911.
http://www.planar.com/products/flatpanel—monitors/stereoscopic/ (Printed Dec. 29, 2011).
InnerAim Brochure; 3D Visualization Software for Simpler, Safter, more Precise Aiming, Published no earlier than Apr. 1, 2010.
International Preliminary Report on Patentability for International Application No. PCT/US2009/032028 (Aug. 5, 2010).
International Search Report and Written Opinion recieved in corresponding PCT Application No. PCT/US2010/024378, mailed Oct. 13, 2010, 9 pages.
InVision System Brochure; A “GPS” for Real-Time 3D Needle Visualization & Guidance, Published no earlier than Mar. 1, 2008.
InVision User Manual; Professional Instructions for Use, Published no earlier than Dec. 1, 2008.
Jacobs et al., “Managing Latency in Complex Augmented Reality Systems,” ACM SIGGRAPH Proceedings of the Symposium of Interactive 3D Graphics 1997, pp. 49-54, available from www.cs.unc.edu/˜us/Latency//ManagingRelativeLatency.html, printed Sep. 20, 2007, 12 pages.
Kanbara et al., “A Stereoscopic Video See-through Augmented Reality System Based on Real-time Vision-Based Registration,” Nara Institute of Science and Technology, pp. 1-8 (2000).
Keller et al., “What is it in Head Mounted Displays (HMDs) that really makes them all so terrible!,” pp. 1-8 (1998).
Lass, “Assessment of Ovarian Reserve,” Human Reproduction, 2004, vol. 19(3), pp. 467-469, available from http://humrep.oxfordjournals.orgcgi/reprint/19/3/467, printed Sep. 20, 2007, 3 pages.
Lee et al, “Modeling Real Objects Using Video See-Through Augmented Reality,” Proceedings of the Second International Symposium on Mixed Reality, ISMR 2001, pp. 19-26 (Mar. 14-15, 2001).
Lee et al., “Modeling Real Objects Using Video See-Through Augmented Reality,” Presence, vol. 11, No. 2, pp. 144-157 (Apr. 2002).
Leven et al., DaVinci Canvas: A Telerobotic Surgical System with Integrated, Robot-Assisted, Laparoscopic Ultrasound Capability, in J. Duncan and G. Gerig (Eds.): MICCAI 2005, LNCS 3749, pp. 811-818, 2005.
Levy et al., An Internet-Connected, Patient Specific, Deformable Brain Atlas Integrated into a Surgical Navigation System, Journal of Digital Imaging, vol. 10, No. 3. Suppl. 1 Aug. 1997: pp. 231-237.
Livingston et al., “Magnetic Tracker Calibration for Improved Augmented Reality Registration,” Presence: Teleoperators and Virtual Environments, 1997, vol. 6(5), pp. 532-546, available from www.cs.unc.edu/˜andrei/pubs/1997—Presence—calibr.pdf, printed Sep. 20, 2007, 14 pages.
Matsunaga et al., “the Effect of the Ratio Difference of Overlapped Areas of Stereoscopic Images on each Eye in a Teleoperation,” Stereoscopic Displays and Virtual Reality Systems VII, Proceedings of SPIE, vol. 3957, pp. 236-243 (2000).
Meehan et al., “Effects of Latency on Presence in Stressful Virtual Environment,” Proceedings of IEEE Virtual Reality 2003, pp. 141-148, available from http://www.cs.unc.edu/˜eve/pubs.html, printed Sep. 20, 2007, 9 pages.
Milgram et al., “Adaptation Effects in Stereo due to Online Changes in Camera Configuration,” SPIE vol. 1669-13, Stereoscopic Displays and Applications III, pp. 1-12 (1992).
Mitchell et al., “Colposcopy for the Diagnosis of Squamous Intraepithelial lesions: A metaanalysis,” Obstetrics and Gynecology; Apr. 1998; 91(4):626-631.
Nakamoto et al., 3D Ultrasound System Using a Magneto-optic Hybrid Tracker for Augmented Reality Visualization in Laparoscopic Liver Surgery, in T. Dohi and R. Kikinis (Eds.): MICCAI 2002, LNCS 2489, pp. 148-155, 2002.
Non-Final Official Action for U.S. Appl. No. 12/609,915 (Nov. 9, 2011).
Non-Final Official Action for U.S. Appl. No. 10/492,582 (Aug. 19, 2008).
Nordstrom et al., “Identification of Cervical Intraepithelial Neoplasia (CIN) Using UV-Excited Fluorescence and Diffuse-Reflectance Tissue Spectroscopy,” Lasers in Surgery and Medicine; 2001; 29; pp. 118-127; Wiley-Liss, Inc.
Notification of Republication for International Application No. PCT/US2009/032028 (Oct. 19, 2009).
Notification of Transmittal of the International Search Report or the Declaration for International Application No. PCT/US02/33597 (June. 25, 2003).
Ohbuchi et al., “Incremental Volume Reconstruction and Rendering for 3D Ultrasound Imaging,” Visualization in Biomedical Computing, SPIE Proceedings, pp. 312-323, (Oct. 13, 1992).
Ohbuchi, “Incremental Acquisition and Visualization of 3D Ultrasound Images,” Ph.D. Dissertation, UNC-CH Computer Science Technical Report TR95-023, (1993).
PCT, The International Search Report of the International Searching Authority, mailed Sep. 9, 2009, for case PCT/US2009/032028.
PCT, The International Search Report of the International Searching Authority, mailed Mar. 3, 2011, for case PCT/US2010/043760.
Pogue et al., “Analysis of acetic acid-induced whitening of high-grade squamous intraepithelial lesions,” Journal of Biomedical Optics; Oct. 2001; 6(4):397-403.
Raij et al., Comparing Interpersonal Interactions with a Virtual Human to Those with a Real Human; IEEE Transactions on Visualization and Computer Graphics 13(3), 443-457 (2007).
Raz et al., “Real-Time Magnetic Resonance Imaging-Guided Focal Laser Therapy in Patients with Low-Risk Prostate Cancer,” European Urology 58, pp. 173-177. Mar. 12, 2010.
Restriction and/or Election Requirement for U.S. Appl. No. 10/492,582 (Apr. 3, 2008).
Robinett et al., “A Computational Model for the Stereoscopic Optics of a Head-Mounted Display,” SPIE vol. 1457, Stereoscopic Displays and Applications II, pp. 140-160 (1991).
Rolland et al., “Towards Quantifying Depth and Size Perception in 3D Virtual Environments,” Presence: Teleoperators and Virtual Environments 4, vol. 1, pp. 1-21 (1995).
Rolland et al., “Towards Quantifying Depth and Size Perception in Virtual Environments,” Presence: Teleoperators and Virtual Environments 4, vol. 1, pp. 24-49 (Winter 1995).
Rolland et al., Towards Quantifying Depth and Size Perception in Virtual Environments, Presence: Teleoperators and Virtual Environments, Winter 1995, vol. 4, Issue 1, pp. 24-49.
Rosenthal et al., “Augmented Reality Guidance for Needle Biopsies: An Initial Randomized, Controlled Trial in Phantoms,” Proceedings of Medical Image Analysis, Sep. 2002, vol. 6(3), pp. 313-320, available from www.cs.unc.edu/˜fuchs/publications/AugRealGuida—NeedleBiop02.pdf, printed Sep. 20, 2007, 8 pages.
Rosenthal et al., “Augmented Reality Guidance for Needle Biopsies: A Randomized, Controlled Trial in Phantoms,” Proceedings of MICCAI 2001, eds. W. Niessen and M. Viergever, Lecture Notes in Computer Science, 2001, vol. 2208, pp. 240-248, available from www.cs.unc.edu/˜us/AugmentedRealityAssistance.pdf.
Splechtna et al., Comprehensive calibration and registration procedures for augmented reality; Proc. Eurographics Workshop on Virtual Environments 2001, 219-228 (2001).
State et al., “Technologies for Augmented-Reality Systems: Realizing Ultrasound-Guided Needle Biopsies,” Proceedings of SIGGRAPH '96, pp. 1-8 (Aug. 1996).
State et al., “Case Study: Observing a Volume Rendered Fetus within a Pregnant Patient,” Proceedings of IEEE Visualization 1994, pp. 364-368, available from www.cs.unc.edu/˜fuchs/publications/cs-ObservVolRendFetus94.pdf, printed Sep. 20, 2007, 5 pages.
State et al., “Interactive Volume Visualization on a Heterogenous Message-Passing Multicomputer,” Proceedings of 1995 Symposium on Interactive 3D Graphics, 1995, pp. 69-74, 208, available from www.cs.unc.edu/˜andrei/pubs/1995—I3D—vol2—Mac.pdf, printed Sep. 20, 2007.
State et al., “Simulation-Based Design and Rapid Prototyping of a Parallax-Free, Orthoscopic Video See-Through Head-Mounted Display,” Proceedings of International Symposium on Mixed and Augmented Reality (ISMAR) 2005, available from www.cs.unc.edu/˜andrei/pubs/2005—ISMAR—VSTHMD—design.pdf, printed Sep. 20, 2007, 4.
State et al., “Stereo Imagery from the UNC Augmented Reality System for Breast Biopsy Guidance” Proc. Medicine Meets Virtual Reality (MMVR) 2003 (Newport Beach, CA, Jan. 22-25, 2003).
State et al., “Superior Augmented Reality Registration by Integrating Landmark Tracking and Magnetic Tracking,” ACM SIGGRAPH Computer Graphics, Proceedings of SIGGRAPH 1996, pp. 429-438, available from www.cs.princeton.edu/courses/archive/fall01/cs597d/papers/state96.pdf, printed Sep. 20, 2007, 10 pages.
State, “Exact Eye Contact with Virtual Humans,” Proc. IEEE International Workshop on Human Computer Interaction 2007, Rio de Janeiro, Brazil, pp. 138-145 (Oct. 20, 2007).
Symons et al., “What are You Looking at? Acuity for Triadic Eye Gaze,” J. Gen. Psychology 131(4), pp. 451-469 (2004).
Takacs et al., “The Virtual Human Interface: A Photorealistic Digital Human,” IEEE Computer Graphics and Applications 23(5), pp. 38-45 (2003).
Takagi et al., “Development of a Stereo Video See-through HMD for AR Systems,” IEEE, pp. 68-77 (2000).
Takayama et al., “Virtual Human with Regard to Physical Contact and Eye Contact,” Kishino, F., Kitamura, U., Kato, H., Nagata, N. (eds) Entertainment Computing 2005, LNCS, vol. 3711, pp. 268-278 (2005).
U.S. Appl. No. 11/828,826, filed Jul. 26, 2007.
Ultraguide 1000 System, Ultraguide, www.ultraguideinc.com, 1998.
van Staveren et al., “Light Scattering in Intralipid—10% in the wavelength range of 400-1100 nm,” Applied Optics; Nov. 1991; 30(31):4507-4514.
Viola et al., “Alignment by Maxmization of Mutual Information,” International Journal of Computer Vision, vol. 24, No. 2, pp. 1-29 (1997).
Viola, Paul A., Alignment by Maximization of Mutual Information, Ph.D. Dissertation, MIT-Artificial Intelligence Laboratory Technical Report No. 1548 (Jun. 1995).
Ware et al., “Dynamic Adjustment of Stereo Display Parameters,” IEEE Transactions on Systems, Many and Cybernetics, vol. 28, No. 1, pp. 1-19 (Publication Date Unknown).
Watson et al., “Using Texture Maps to Correct for Optical Distortion in Head-Mounted Displays,” Proceedings of the Virtual Reality Annual Symposium '95, IEEE, pp. 1-7 (1995).
Welch, Hybrid Self-Tracker: An Inertial/Optical Hybrid Three-Dimensional Tracking System, University of North Carolina Chapel Hill Department of Computer Science, TR 95-048.
Yinghui et al., “Real-Time Deformation Using Modal Analysis on Graphics Hardware,” Graphite 2006, Kuala Lumpur, Malaysia, Nov. 29-Dec. 2, 2006.
Zitnick et al., “Multi-Base Stereo Using Surface Extraction,” Visual Interface Inc., (Nov. 24, 1996).
Ohbuchi et al., “An Incremental Volume Rendering Algorithm for Interactive 3D Ultrasound Imaging,” UNC-CH Computer Science Technical Report TR91-003 (1991).
Notice of Abandonment for U.S. Appl. No. 12/609,915 (Jan. 3, 2013).
Final Official Action for U.S. Appl. No. 12/609,915 (May 25, 2012).
Caines et al., “Stereotaxic Needle Core Biopsy of Breast Lesions Using a Regular Mammographic Table with an Adaptable Stereotaxic Device,” American Journal of Roentgenology, vol. 163, No. 2, pp. 317-321, Downloaded from www.ajrorline.org on Jul. 10, 2013 (Aug. 1994).
Dumoulin et al., “Real-Time Position Monitoring of Invasive Devices Using Magnetic Resonance,” Magnetic Resonance in Medicine, vol. 29, Issue 3, pp. 411-415 (Mar. 1993).
Fuchs et al., “Optimizing a Head-Tracked Stereo Display System to Guide Hepatic Tumor Ablation,” Departments of Computer Sciences and Radiology and School of Medicine, University of North Carolina at Chapel Hill; InnerOptic Technology, Inc., pp. 1-6 (2008).
Fuchs et al., “Virtual Environments Technology To Aid Needle Biopsies of the Breast,” Health Care in the Information Age, Ch. 6, pp. 60-61, Presented in San Diego, Jan. 17-20, 1996, published by IOS Press and Ohmsha (Feb. 1996).
Jolesz et al., “MRI-Guided Laser-Induced Interstitial Thermotherapy: Basic Principles,” SPIE Institute on Laser-Induced Interstitial Thermotherapy (L1TT), pp. 1-17 (Jun. 22-23, 1995).
Kadi et al., “Design and Simulation of an Articulated Surgical Arm for Guiding Stereotactic Neurosurgery,” SPIE vol. 1708 Applications of Artificial Intelligence X: Machine Vision and Robotics, pp. 1-18, Downloaded from: http://proceedings.spiedigitallibrary.org/ on Jul. 11, 2013 (1992).
Kato et al., “A frameless, armless navigational system for computer-assisted neurosurgery,” Journal of Neurosurgery, vol. 74, No. 5, pp. 845-849 (May 1991).
PCT International Search Report and Written Opinion of the International Searching Authority for International Application No. PCT/US07/75122 (Aug. 20, 2008).
PCT International Preliminary Report on Patentability (Chapter 1) for International Application No. PCT/US07/75122 (Mar. 3, 2009).
PCT International Search Report and Written Opinion of the International Searching Authority for International Application No. PCT/US2013/023678 (Jun. 13, 2013).
PCT International Preliminary Report on Patentability (Chapter 1) for International Application No. PCT/US2013/023678 (Aug. 5, 2014).
Screenshots from video produced by the University of North Carolina, produced circa 1992.
State et al., “Contextually Enhanced 3D Visualization fro Multi-Born Tumor Ablation Guidance,” Departments of Computer Science and Radiology and School of Medicine, University of North Carolina at Chapel Hill; InnerOptic Technology, Inc., pp. 70-77, (2008).
Related Publications (1)
Number Date Country
20110046483 A1 Feb 2011 US
Provisional Applications (1)
Number Date Country
61023268 Jan 2008 US
Continuations (1)
Number Date Country
Parent PCT/US2009/032028 Jan 2009 US
Child 12842261 US